🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Are you at #OptionsXI this week? Make sure to check out the COS poster on #openscience on Wednesday! And learn more about our Flu Lab-funded open science fellowship for #influenza researchers: cos.io/flulab. OPTIONS XI

Stop by to check out our poster at #OptionsXI! Topic: Most Influenza Researchers Personally Support #OpenScience. Why Are So Few Doing It? While you're there, learn more about our Flu Lab-funded open science fellowship for #influenza researchers! cos.io/flulab

Just a few days left to apply for the Open Science Fellowship for Influenza Researchers! With funding from Flu Lab, COS is recruiting influenza and public health researchers to promote #openscience in their communities. Apply by Oct. 14: cos.io/flulab.

We are committed to advancing the development of better tools to fight influenza - and that includes improving how those tools are evaluated. We are excited to support Protas and share their vision for smarter clinical trials.

Excited to see Fast Company sharing how the Kinsley Ailshire forecast is helping brands and retailers plan during this unprecedented illness season. #demandplanning #kinsainsights #publichealth #brands #retailers fastcompany.com/90812898/the-w…

Knowledge♻️between flu and Covid-19 on transmission, viral interference, interventions, long flu/Covid. At-home rapid flu tests would be awesome! nbcnews.com/health/health-… with NIAID News Seema_Lakdawala 🏳️‍🌈 Prof. Akiko Iwasaki and me.

New influenza vaccines need new evaluation tools. ISIRV seeks abstracts for their “Correlates of Protection for Next Generation Influenza Vaccines” mtg Mar 2023. Learn more: isirv.org/site/index.php…

Proud to share that today we opened for enrollment in INVITED, an RCT testing if influenza vaccine can mitigate type 1 diabetes NCT05585983 Dr. Deepak L. Bhatt Prof Chris P Gale John Paget, PhD @ECDC_Flu Influenza Virus Mads Fuglsang Kjølby Niels Jessen Troels Krarup Hansen Sunil V. Rao @RHollingsworth2 Research @ Steno Diabetes Center Aarhus

BARDA’s IEID Division seeks presentation submissions of host-directed therapeutic candidates from drug sponsors to address acute respiratory distress syndrome (#ARDS), to join our virtual product pitch competition, Just Breathe – An ARDS Therapeutics Pitch Event July 24-28, 2023.

Thrilled The Atlantic highlighted our new work on flu transmission - big shout out to Nicole Rockey and our whole mitigate flu team Linsey Marr https://www.threads.net/@linseycmarr @MartinEpi Anice Lowen (to name a few) and Flu Lab for funding this ‘crazy’ idea!!

1/ 🧬 Exciting update for #CRISPR diagnostics! In our pre-print, we develop innovative bead-based techniques targeting both sensitivity and multiplexability of CRISPR-based diagnostics. Dive into our pre-print: medrxiv.org/content/10.110… Cameron Myhrvold sabeti_lab Blainey Lab

Human challenge studies are critical for vaccine development. NIAID News is excited to inform the research community of the limited availability of cGMP material for controlled human influenza virus infection model (CHIVIM) clinical studies and trials. grants.nih.gov/grants/guide/n…

We are thrilled to announce a new collaboration with University of Oxford 🫱🏼‍🫲🏾 After having recruited over 48,000 patients in the UK, Asia & Africa, the #RECOVERYtrial will take advantage of Ecraid's expertise & warm-base network to extend to Europe. Read more 👉🏼ecraid.eu/projects/ecrai…

1) OUR 2nd PREPRINT! I'm delighted to show you the work the New York City Virus Hunters have been doing over the last two years!

📣📣 Exciting announcement: Late Breaking Orals and Posters have opened! OPTIONS XII 2024 would like to announce that we have opened Late Breaking abstract submissions from Monday 6 May to Thursday 11 July 2024!

U-M receives $6.7M grant to study flu immunity in children No parent wants to see their baby sick. But a child’s first exposure to influenza is actually very important—it can impact their natural protection against future flu viruses. This process, called imprinting, in which

🚨New Paper in nature🚨 To simplify & speed up COVID vaxxes in mid-2021, the White House announced free Uber & @Lyft rides to vax sites. Great idea, right? We ran a HUGE experiment: Do free round-trip @Lyft rides to pharmacies boost vaccination? A🧵 nature.com/articles/s4158…

Influenza & virology researchers: Ready to embrace #OpenScience? 🔬 Our Flu Lab-supported resources include training materials, teaching frameworks, and more to help you integrate practices like preregistration and data sharing into your work. cos.io/flu-lab

10 days till Options2024 where we kick off with the mini school of influenza! Sponsored by Flu Lab and Sanofi With experts Erik Karlsson Florian Krammer TompkinsLab Kirsty Short and more! optionsxii2024.org.uk/programme/mini…

We've been helping the #RECOVERYtrial expand to 6 new European countries: 🇧🇪🇪🇸🇵🇹🇸🇪🇪🇪🇷🇴 Together with new and existing sites in 🇫🇷 🇮🇹 🇳🇱, our team has selected 56 sites, of which 9 are already enrolling patients. Follow the study's progress in Europe 👉🏾 ecraid.eu/study/recovery